Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
FDNA Launches Face2Gene LABS to Accelerate Genetic Disease Diagnoses
The article describes how FDNA launched Face2Gene LABS, an advanced suite of tools that accelerates the diagnosis of genetic diseases. Leveraging artificial intelligence and deep learning, Face2Gene LABS analyzes facial photos to identify phenotypic traits associated with various genetic disorders. This innovative technology promises to enhance the accuracy and speed of genetic testing by providing healthcare professionals with a powerful diagnostic aid. By integrating facial analysis into genetic testing processes, Face2Gene LABS aims to streamline the identification of genetic conditions, improving patient outcomes and supporting clinicians in delivering precise, personalized medical care. Overall, this groundbreaking approach represents a significant advancement in the field of medical genetics.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…